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ABBREVIATIONS
DMD Duchenne muscular dystrophy
HRQOL Health-related quality of life
HUI Health Utilities Index
Questionnaire
PedsQL Pediatric Quality of Life
Inventory
AIM To estimate health-related quality of life (HRQOL) in patients with Duchenne muscular
dystrophy (DMD).
METHOD HRQOL was assessed using the Health Utilities Index Questionnaire (HUI) and the
Pediatric Quality of Life Inventory (PedsQL) neuromuscular module version 3.0 online.
Results were stratified by disease stage (early/late ambulatory/non-ambulatory) and
caregivers’ perceptions of patients’ health and mental status.
RESULTS A total of 770 patient–caregiver pairs (173 German, 122 Italian, 191 UK, and 284
USA) participated. Most caregivers (>84%) perceived their patients as happy/somewhat happy
and in excellent/very good/good health, irrespective of current ambulatory class. In contrast,
mean patient utility (reflecting public preferences: 0, dead; 1, perfect health) deteriorated with
disease course, from 0.75 in early ambulatory males to 0.15 in the most severely affected
patients. Mean patient PedsQL scores (0–100, higher score indicating better HRQOL)
decreased from 80 to 57 across ambulatory classes.
INTERPRETATION HRQOL in DMD, measured through public preferences, is substantially
impaired in relation to the general population and significantly associated with disease
progression. Still, most patients are perceived as happy and in good health by their
caregivers, indicating that influential domains of HRQOL remain intact through the disease
progression. Our findings emphasize the challenges in measuring HRQOL in a rare,
progressive childhood condition such as DMD.
The World Health Organization defines quality of life as
individuals’ perceptions of their position in life in the con-
text of the culture and value systems in which they live and
in relation to their goals, expectations, standards, and con-
cerns.1 Health-related quality of life (HRQOL), in con-
trast, refers specifically to the individual’s perception of the
impact of health and illness on physical, mental, and social
aspects of life.2,3
Following improvement in survival in many chronic dis-
eases, as well as increased requirements of evidence in
terms of patient-reported outcomes by regulatory agencies
such as the US Food and Drug Administration, HRQOL
has emerged as a central outcome both in clinical practice
and in trials of new treatments. However, measuring
HRQOL is challenging because aspects within physical,
mental, and social life have different meanings and implica-
tions on HRQOL for each individual. In addition, chil-
dren, adolescents, and adults have different reference
systems and thus differ in their perceptions of HRQOL
and its determinants.2 The individual’s subjective percep-
tion of HRQOL may also change over time with age, as
the disease progresses, or when new treatments become
available.3,4
A genetic, terminal illness in which survival has
improved substantially during recent decades is Duchenne
muscular dystrophy (DMD). DMD is a rare neuromuscular
disease characterized by progressive muscle weakening,
inevitable loss of independent ambulation, and a wide array
of serious multisystem complications, including cardiomy-
opathy and respiratory muscle dysfunction.5 Untreated,
mean age at death is about 19 years; however, after the
implementation of respiratory support and proactive car-
diac management, many patients with DMD now live to
experience their third and sometimes fourth decade.6
Despite its central role in palliative DMD care, large
series of HRQOL data in DMD are lacking. Existing evi-
dence is usually restricted to one clinic or country and
limited by small sample sizes (fewer than 60 cases) and/or
inadequate stratification across age groups or stages of dis-
ease.7–18 The objective of this study was to estimate
HRQOL in patients with DMD at different stages of
disease progression.
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METHOD
Participants and outcome measures
This was a cross-sectional, observational study of patients
with DMD from Germany, Italy, the UK, and the USA
identified through national DMD registries that form
part of the global TREAT-NMD Neuromuscular Net-
work (http://www.treat-nmd.eu/). Patients were required
to fulfil the following criteria: (1) male, (2) DMD diag-
nosis confirmed by genetic testing, and (3) age at least
5 years.
Eligible patients and one of their caregivers (e.g. a par-
ent) were invited via e-mail to complete the Health Utili-
ties Index Questionnaire (HUI) and the Pediatric Quality
of Life Inventory (PedsQL) neuromuscular module version
3.0 online.11,19 The HUI is a generic HRQOL instrument
encompassing 16 questions covering eight dimensions
(hearing, speech, ambulation/mobility, pain, dexterity, self-
care, emotion, and cognition). Outcomes of the HUI are
linked to preference measurements from the general pub-
lic, representing mean community utilities ranging from 0
(dead) to 1 (perfect health). The HUI has been validated
for proxy-assessments in ages 5 years and older.19
The PedsQL is a construct encompassing disease-
specific HRQOL dimensions relevant to children with
neuromuscular disorders, and has been validated for use
with DMD.11 It consists of 25 questions covering three
domains: (1) about my/my child’s neuromuscular disease
(17 questions related to the disease process and associated
symptomatology); (2) communication (three questions
related to the patient’s ability to communicate with health
care providers and others about his/her illness); and (3)
about our family resources (five questions related to family
financial and social support systems). For each question,
respondents are asked to indicate to what degree a state-
ment has been true during the previous month (five
response categories, ranging from ‘never’ to ‘almost
always’). Questions within the PedsQL are transformed to
a scale ranging from 0 to 100, where a higher score indi-
cates higher HRQOL. We asked patients to complete self-
report versions of the PedsQL (formats available for ages
5–7y, 8–12y, and 13–18y) and the caregivers to complete
proxy-report versions for the same age groups. We also
asked the caregivers to indicate if their patients completed
the PedsQL on their own (i.e. without any support, expla-
nation, or suggestions); only those who did so were
included for analysis.
Bi-monthly reminders, as well as study invitations via
regular post, were sent out by the participating TREAT-
NMD registries. All participants provided informed
consent. Ethical approval for the study was granted from
Ludwig-Maximilians-Universit€at M€unchen (Germany),
Comitato Etico IRCCS E. Medea – Associazione La Nos-
tra Famiglia (Italy), North East Research Ethics Service,
NHS (UK), and the Western Institutional Review Board
(USA). Approval was also obtained from the TREAT-
NMD Global Databases Oversight Committee.
Statistical analysis
We assessed mean HUI-derived utilities and mean PedsQL
scores (caregiver proxy-assessed and patient self-assessed).
We related our results to the progression of DMD by clas-
sifying patients into four groups defined in terms of cur-
rent ambulatory status and age: (1) early ambulatory
(approximate age 5–7y); (2) late ambulatory (approximate
age 8–11y); (3) early non-ambulatory (approximate age
12–15y); and (4) late non-ambulatory (approximately 16y
of age or older).5 We also stratified our estimates by the
caregivers’ subjective ratings of their patients’ current
health (five categories, ranging from ‘poor’ to ‘excellent’)
and the caregivers’ subjective rating of their patients’
current mental status (five categories, ranging from ‘so
unhappy that life is not worthwhile’ to ‘happy and inter-
ested in life’).
Agreement between patients’ self-assessments and care-
givers’ proxy-assessments of PedsQL scores were investi-
gated by estimating intraclass correlations from one-way
random-effects models. We considered intraclass correla-
tion coefficients less than 0.40 to indicate poor/fair agree-
ment, 0.40 to 0.60 moderate agreement, 0.61 to 0.80 good
agreement, and greater than 0.80 excellent agreement.11,12
We assumed the sampling distributions of the sample
means to be approximately normally distributed in accor-
dance with the central limit theorem, and used Welch’s
analysis-of-variance models to compare estimates across
strata and Welch’s t-tests for pairwise comparisons due to
heterogeneous variances. We considered p<0.05 to be
significant. All analyses were conducted in STATA 12
(StataCorp LP, College Station, TX, USA).
RESULTS
A total of 770 patients with DMD completed the question-
naire together with one of their caregivers (Table I). The
overall study response rate was 42%. Caregivers had a
mean age of 44 years (range 23–76) and 95% were parents
to the participating patients. Additional details of the study
sample have been published previously.20,21
Patient HRQOL assessed by the caregivers
Irrespective of current ambulatory class, most (>84%)
patients were perceived as happy or somewhat happy, and
in excellent, very good, or good health, by their caregivers
(Fig. 1). In contrast, we observed a dramatic decrease in
patient HRQOL, measured as HUI-derived utilities repre-
senting public preferences, over the course of disease pro-
gression, ranging from 0.75 in early ambulatory patients
What this paper adds
• Duchenne muscular dystrophy has a detrimental impact on health-related
quality of life (HRQOL) measured through public preferences.
• HRQOL measured through public preferences deteriorates with disease
progression.
• Still, most caregivers perceive patients as happy and in good health.
• Our data suggest patients adapt to their changing health states.
• Measuring self-perceived HRQOL in a rare, genetic disease is challenging.
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(approximate age 5–7y) to 0.15 in late non-ambulatory
patients (approximately 16y of age or older) (p<0.001)
(Fig. 2a). Mean HUI-derived utility was also significantly
associated with the caregivers’ rating of their patients’ cur-
rent health (p<0.001) (Fig. 2b), and rating of their patients’
current mental status (p<0.001) (Fig. 2c). HUI-estimates
were comparable across countries (p=0.165).
Caregiver proxy-assessed PedsQL total scores were sig-
nificantly associated with ambulatory class (mean score
range 52–72, p<0.001), but similar for early and late ambu-
latory patients, and early and late non-ambulatory patients,
and significantly associated with the caregivers’ rating of
their patients’ current health (mean score range 26–73,
p<0.001) and the caregivers’ rating of their patients’ cur-
rent mental status (mean score range 43–67, p<0.001)
(Fig. 2). The mean HUI-derived utility and PedsQL total
score in patients requiring ventilation support was esti-
mated at 0.10 and 48 respectively. Across countries, proxy-
assessed mean PedsQL total scores ranged between 58 and
65 (p=0.001).
Patient self-assessment of their HRQOL
A total of 518 (67%) patients (mean age 15y, range 5–43y)
were able to complete the PedsQL without help from their
caregivers. The mean self-assessed PedsQL total score was
estimated to be between 57 and 80 across ambulatory
classes (p<0.001) (Fig. 2a), between 26 and 76 across the
caregivers’ rating of their patients’ current health (p<0.001)
(Fig. 2b), and between 50 and 73 across the caregivers’ rat-
ing of their patients’ current mental status (p<0.001)
(Fig. 2c). The mean score in patients requiring ventilation
support was 52.
Although the mean PedsQL score was similar across
countries (p=0.105), there were differences in the areas
reported to be of most concern. German and Italian
patients indicated most frequent problems with turning at
night, waking up tired, difficulties in using the bathroom,
and planning family activities like vacations. In the UK
sample, in addition to tiredness, patients indicated most
frequent problems in their families not getting enough rest
and planning family activities. US patients indicated most
problems with pain in their legs, tiredness, and explaining
their illness to other people. Approximately 20% of Ger-
man patients indicated that they often or always lacked the
equipment they needed. The corresponding proportions of
the Italian, UK, and US sample were 6%, 17%, and 11%
respectively.
Comparison of self- and proxy-assessment of patient
HRQOL
Patients’ self-assessed PedsQL total scores were consis-
tently higher than caregivers’ proxy-assessed scores across
the investigated strata (Fig. 2). Intraclass correlation coeffi-
cients between the patients’ and caregivers’ total scores
were estimated between 0.56 and 0.79 across ambulatory
classes (indicating moderate to good agreement), 0.64 and
0.94 across caregivers’ rating of their patients’ current
health (good to excellent agreement), and 0.64 and 0.77
across caregivers’ rating of their patients’ current health
(good agreement). For the pooled sample, the intraclass
correlation coefficient was estimated as 0.78 (good agree-
ment) (Table II).
DISCUSSION
Children with DMD are born into a life of chronic illness,
inexorably increasing physical disability and dependence,
and knowledge of an inevitably premature death. Com-
pared with the reference points of a healthy peer, this life
would appear bleak. However, from the perspective of the
affected individuals, who do not know any other life, they
may perceive their well-being differently. With these pre-
mises in mind, we set out to measure HRQOL in children,
adolescents, and young adults with DMD. In addition to
informal assessment of current health and mental status,
we used two validated instruments: one generic linked to
public preferences and one disease-specific, in search of a
more complete picture of HRQOL along the progression
of DMD.
Despite the considerable morbidity associated with the
disease, the vast majority of patients with DMD in our
sample were perceived as happy and in good health by
their caregivers, with only minor variation across ambu-
latory classes or needs of ventilation support for sur-
vival. Contrary to these findings, our estimates of mean
proxy-assessed patient HUI-derived utility (representing
HRQOL as measured by members of the public) was
strongly negatively associated with disease progression and
substantially lower than reference values for Canadian chil-
dren and young adults (0.94).22 For non-ambulatory
Table I: Demographic statistics of the patients with Duchenne muscular
dystrophy (n=770)
n (proportion, %)
Country of residence (%)
Germany 173 (22)
Italy 122 (16)
UK 191 (25)
USA 284 (37)
Mean age (SD), y 14 (7)
Ventilation support 126 (16)
Current ambulatory status (%)
Early ambulatory (approximate age 5–7y) 155 (20)
Late ambulatory (approximate age 8–11y) 256 (33)
Early non-ambulatory (approximate age
12–15y)
154 (20)
Late non-ambulatory (approximate 16y
of age or older)
205 (27)
Accommodation (%)
Home of parents 726 (94)
Home of other relative 12 (2)
Own home 28 (4)
Group home or care facility 4 (1)
Current situation (%)
Attending school, college, or university 591 (77)
Employed 21 (3)
Unemployed 158 (21)
Because of rounding, percentages might not add up to 100%
exactly.
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patients (approximate age ≥12y), our mean utility estimate
(0.19) was also lower than published estimates for other
chronic, non-progressive conditions such as cerebral palsy
(0.28), Down syndrome (0.36), deafness (0.42), and autism
spectrum disorder (0.43), as well as previous utility esti-
mates for muscular dystrophy and spinal muscular atrophy
(0.39).23 The minimum meaningful change in HUI scores
has been estimated to be between 0.03 and 0.05.19 The
mean utility change from the early ambulatory to the late
non-ambulatory class of 0.60 observed in our study thus
indicates a loss in HRQOL of extraordinary magnitude.
There are several possible reasons for the observed dis-
crepancy between HUI-derived utilities and the caregivers’
ratings of patients’ health and mental status across ambula-
tory classes (e.g. low utility estimates for patients perceived
to be happy and in good health). First, given the inherently
progressive nature of DMD, patients and their caregivers
may be subject to a phenomenon known as ‘response shift’
or ‘well-being paradox’, which is the process of adapting to
a changed health state and of accommodating illness.2
Caregivers may also adjust their perception of their
patients’ HRQOL based on disease history as well as the
anticipated disease trajectory (where the current health
state may appear relatively good given the expected well-
being in more advanced stages of DMD). Lastly, since
DMD is a genetic condition, patients are not familiar with
a life free from disease, and do not have the same refer-
ences as healthy individuals against which to compare their
current situation. Findings similar to ours have been
reported for individuals with, for example, cerebral palsy,
who have been shown to have comparable HRQOL as
their healthy peers,24 but also very poor HRQOL as mea-
sured through public preferences using the HUI.23
Previously published data on the association between
DMD progression and HRQOL are limited by small sample
sizes and based on many different ratings scales, which make
comparisons between studies challenging. Bray et al. show
in two studies of 34 and 35 Australian patients with DMD
respectively that patient HRQOL is significantly negatively
associated with physical functioning but uncorrelated with
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Figure 1: Caregivers’ ratings of patients’ current health (a) and mental status (b).
Health-Related Quality of Life in DMD Erik Landfeldt et al. 511
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
0
10
20
30
40
50
60
70
80
90
100
Excellent
(n=145)
Very good
(n=321)
Good
(n=228)
Fair
(n=70)
Poor
(n=6)
M
ea
n 
Pe
ds
QL
 to
ta
l s
co
re
Caregivers' rating of their patients' current health
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
0
10
20
30
40
50
60
70
80
90
100
Early
ambulatory
(n=155)
Late
ambulatory
(n=256)
Early non-
ambulatory
(n=154)
Late non-
ambulatory
(n=205)
M
ea
n 
H
UI
-d
er
ive
d 
ut
ilit
y
M
ea
n 
H
UI
-d
er
ive
d 
ut
ilit
y
M
ea
n 
H
UI
-d
er
ive
d 
ut
ilit
y
M
ea
n 
Pe
ds
QL
 to
ta
l s
co
re
Current ambulatory status
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
0
10
20
30
40
50
60
70
80
90
100
Happy and
interested in life
(n=455)
Somewhat
happy
(n=239)
Somewhat
unhappy
(n=63)
Very
unhappy
(n=13)
M
ea
n 
Pe
ds
QL
 to
ta
l s
co
re
Caregivers' rating of their patients' current mental status
*
PedsQL (caregiver assessment)
PedsQL (self-assessment)
HUI utility (caregiver assessment)
*
*
*
*
*
*
*
(a)
(b)
(c)
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psychosocial well-being.7,15 Comparable findings were
reported by Kohler et al.16 in a study of 35 Swiss patients,
Uzark et al.12 in a study of 117 US patients, and Elsenbruch
et al.17 in a study of 50 German patients. In the last two
studies, older males/adolescents were found to have even
better psychosocial health than their younger counterparts.
A negative association between HRQOL and wheelchair use
and ventilation support was also found in a study of 27 Ital-
ian patients with DMD by Baiardini et al.8 Our results
expand on these previous reports and provide valuation of
patient HRQOL from the perspective of the public appro-
priate for use in health economic evaluations as recom-
mended by the National Institute for Health and Care
Excellence in the UK. Our findings should also be helpful in
informing decisions about clinical trial endpoints defined in
terms of HRQOL outcomes given the observed pattern of
deterioration across the disease course; however, they
emphasize that any measurement of self-perceived HRQOL
in a paediatric disease such as DMD needs to be interpreted
with caution.
We estimated the mean patient self-assessed PedsQL
total score to be between 26 and 80 across the investigated
strata. Only two studies have, to our knowledge, assessed
HRQOL in patients with DMD using the neuromuscular
version of PedsQL, and they estimated the mean parent-
proxy score at 60 and 53 respectively.11,13 However, inter-
preting and comparing PedsQL outcomes is challenging
because the scoring algorithm does not take into account
that the impact on HRQOL from the questions and
response categories included in the instrument is likely to
vary across respondents. For example, a child indicating
that he always has problems explaining his disease to other
people is attributed the same loss in HRQOL as a child
indicating the he always feels tired, although the impact on
HRQOL may be very different. In addition, the impact on
HRQOL of, for example, always feeling tired would be
expected to vary across individuals. In other words, the
PedsQL measures HRQOL on an ordinal scale and fails to
incorporate the heterogeneity in the determinants of
HRQOL across respondents, as well as the potential inter-
action between different questions and response categories
and HRQOL.
In our sample, one-third of all patients (252/770) were
unable to complete the PedsQL without help from their
caregivers, and for this subgroup the mean PedsQL total
score was slightly higher but not significantly different
than scores for those who completed the instrument on
their own (69 compared with 67, p=0.079). The caregiver
proxy-assessed mean PedsQL total score for these patients
was also higher (63 compared with 61, p=0.089), as well as
mean HUI-derived patient utility (0.52 compared with
0.42, p<0.001). Data on why some patients could not pro-
vide self-assessments were not collected as part of the
study, but possible reasons include cognitive problems,
which are prevalent in DMD, as well as issues in interpret-
ing language and meaning of questions among younger
respondents (even though we used age-specific formats), as
noted in studies of other paediatric populations.2
Although our findings generally were comparable across
countries, we found some differences in PedsQL results.
A potential reason for this finding includes differences in
general population HRQOL (e.g. generally lower
HRQOL for those living in the UK compared with the
USA) as suggested by, for example, EuroQol EQ-5D
value sets,25 but the differences cannot be fully analysed
in our data set and warrant further investigation. Other
factors of importance may relate to cultural differences in
care experiences and expectations. Moreover, in the
PedsQL, about one in every five German patients indi-
cated that they often or always lacked the equipment they
needed. This finding is in agreement with our previous
report of discrepancies between real-world care and DMD
care guidelines, where, for example, only 29% of German
patients reported having access to any orthosis compared
with 65%, 65%, and 70% in Italy, the UK, and the USA
respectively.21 Affordable access to medical devices and
aids is central to help maintain HRQOL and allow
patients with DMD to participate in society as their phys-
ical functioning deteriorates.
Historically, in research of HRQOL in paediatric popu-
lations, proxy-reports by, for example, caregivers or physi-
cians have been used when the child is too ill or deemed
cognitively incapable of making reliable assessments.
Today, with the development of age-specific instruments,
the consensus is that children can and should report their
own HRQOL. However, the use of proxy-reports is also
encouraged as they may provide additional, complementary
HRQOL data.2 In our study, patients consistently ranked
their HRQOL more favourably than their caregivers. Still,
we noted good to excellent agreement between proxy- and
self-assessments of patient HRQOL, with the exception of
the PedsQL cluster ‘About our family resources’ (where
agreement was moderate). Thus, our findings indicate less
discrepancy than previous research reporting poor to
fair,11,12 poor to fair to moderate,7 moderate,13 and moder-
ate to good agreement.14 Potential reasons include differ-
ences between studies in, for example, the distribution of
patients across disease stages, patient–caregiver relation-
ships (parents vs more distant relatives), and extent of
Table II: Comparison of self- and proxy-assessments of patient health-
related quality of life
Patient
self-
assessment
score
Caregiver
proxy-
assessment
score
Intraclass
correlation
coefficient
PedsQL total score 67 (65–68) 61 (60–63) 0.78 (0.74–0.81)
About my/my child’s
neuromuscular
disease
66 (64–68) 64 (62–65) 0.84 (0.81–0.87)
Communication 68 (65–70) 60 (57–62) 0.67 (0.62–0.72)
About our family
resources
67 (64–69) 54 (52–56) 0.57 (0.50–0.63)
Data presented as mean (95% CI). PedsQL, Paediatric Quality of Life
Inventory neuromuscular module version 3.0.
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caregiver involvement in the daily life of the patient with
DMD.
A limitation of our study relates to the generalizability
of results. Patients were recruited via TREAT-NMD reg-
istries with a mean response rate of 42%, and as participa-
tion in the registries is voluntary and family-initiated, we
cannot rule out a degree of selection bias. However, given
that the collected clinical and epidemiological data were
characteristic for the different patient groups (not
reported), that our sample was evenly distributed across
the defined ambulatory classes, and that the distribution of
ages was similar for responders and non-responders, the
discrepancy between the sample and study populations
should be limited. It is also worth pointing out that the
response rate among those who actually received a study
invitation would be expected to be higher as a result of,
for example, lost invitations due to recent changes to
e-mail addresses and spam filters.
In summary, we show that HRQOL in DMD, mea-
sured through public preferences, is substantially impaired
in relation to general population reference values, strongly
negatively associated with disease progression, and in
good agreement with the caregivers’ subjective percep-
tions of their patients’ current health and mental status.
Still, most children and young adults with DMD are
rated as happy and in good health by their caregivers,
irrespective of current ambulatory class, indicating that
some domains of HRQOL remain intact through the
progression of DMD. Our findings also emphasize the
challenges in measuring HRQOL in paediatric popula-
tions in general, and a rare, progressive childhood disease
such as DMD in particular.
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